SCHEMBL8348295

SCHEMBL8348295

Clc1ccc(OC2=CCCC=C2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 1/20 0.41
MAOB P27338 1/20 0.41
ALDH1A1 P00352 3/20 0.38
LMNA P02545 2/20 0.38
LTA4H P09960 6/20 0.35
MEN1 O00255 4/20 0.34
KMT2A Q03164 4/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
KDM4E B2RXH2 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP2D6 P10635 1/20 0.34
MAPT P10636 1/20 0.34
CYP2C9 P11712 1/20 0.34
HPGD P15428 1/20 0.34
CYP2C19 P33261 1/20 0.34
NPSR1 Q6W5P4 2/20 0.33
PTGS2 P35354 1/20 0.33
HAO1 Q9UJM8 1/20 0.33
NPC1 O15118 1/20 0.32
GAA P10253 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12153390 0.81 ALDH1A1 (0.48) MAOAMAOBALDH1A1LTA4HMEN1
SCHEMBL18726479 0.81 ESR2 (0.48) LTA4HMEN1KMT2A
SCHEMBL21540141 0.81 LTA4H (0.46) MAOAMAOBLTA4H
SCHEMBL13019820 0.81 TEAD4 (0.41) ALDH1A1LMNAMEN1KMT2ASMN1; SMN2
SCHEMBL10273562 0.80 LTA4H (0.44) MAOAMAOBLTA4HKMT2AKDM4E
SCHEMBL14081102 0.77
SCHEMBL19346893 0.77 RAB9A (0.46) MAOBALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL7540308 0.76
SCHEMBL19075410 0.74 MCHR1 (0.34) LTA4HMEN1KMT2ASMN1; SMN2NPSR1
SCHEMBL25039155 0.74 ALDH1A1 (0.38) ALDH1A1LMNAMEN1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004002483-A1 SUBSTITUTED 3- AND 4- AMINOMETHYLPIPERIDINES FOR USE AS BETA-SECRETASE IN THE TREATMENT OF ALZHEIMER’S DISEASE ACTELION PHARMACEUTICALS LTD (CH) 2004-01-08 WO disclosed